TheStreet's Jim Cramer says DuPont (DD) did a good job cutting costs in its latest earnings report, but he still questions whether the company's merger with Dow Chemical (DOW) will go through. If it doesn't, he prefers Dow.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.